Literature DB >> 10615446

The lens paradigm in experimental myopia: oculomotor, optical and neurophysiological considerations.

D I Flitcroft1.   

Abstract

The lens-rearing paradigm has developed great importance in the field of experimental myopia. Although an apparently simple paradigm, the results of any experiment can be influenced by a variety of factors including habitual viewing distance, ocular refraction, oculomotor performance and the spatial sensitivity of the retinal elements involved in retinal image assessment. Computer modelling has been used to evaluate the expected impact when lenses are placed in front of a primate eye as a function of the above parameters. Spatial band-pass responses of the mechanisms responsible for emmetropization are predicted to lead to a limited range of retinal defocus over which compensation to lenses could occur. Even assuming an equal ability to detect hyperopic and myopic defocus, it is predicted that primate eyes should be able to compensate for a much larger range of minus lenses than plus lenses. This derives from the ability of the accommodation system to keep retinal defocus within this operating range over a wider range of minus lenses than plus lenses. The range over which compensation can occur will depend on the spatial tuning of the elements responsible for detecting retinal defocus and capabilities of the accommodation system. The observed asymmetry in responses of the primate eye to rearing with plus and minus lenses and observed differences between primates and chickens in lens rearing studies may therefore be partly attributable to optical and neurophysiological considerations.

Entities:  

Mesh:

Year:  1999        PMID: 10615446     DOI: 10.1046/j.1475-1313.1999.00432.x

Source DB:  PubMed          Journal:  Ophthalmic Physiol Opt        ISSN: 0275-5408            Impact factor:   3.117


  9 in total

Review 1.  Emmetropisation and the aetiology of refractive errors.

Authors:  D I Flitcroft
Journal:  Eye (Lond)       Date:  2014-01-10       Impact factor: 3.775

Review 2.  IMI - Report on Experimental Models of Emmetropization and Myopia.

Authors:  David Troilo; Earl L Smith; Debora L Nickla; Regan Ashby; Andrei V Tkatchenko; Lisa A Ostrin; Timothy J Gawne; Machelle T Pardue; Jody A Summers; Chea-Su Kee; Falk Schroedl; Siegfried Wahl; Lyndon Jones
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-02-28       Impact factor: 4.799

3.  Integration of defocus by dual power Fresnel lenses inhibits myopia in the mammalian eye.

Authors:  Sally A McFadden; Dennis Y Tse; Hannah E Bowrey; Amelia J Leotta; Carly S Lam; Christine F Wildsoet; Chi-Ho To
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-14       Impact factor: 4.799

4.  The Study of Progression of Adult Nearsightedness (SPAN): design and baseline characteristics.

Authors:  Mark A Bullimore; Kathleen S Reuter; Lisa A Jones; G Lynn Mitchell; Jessica Zoz; Marjorie J Rah
Journal:  Optom Vis Sci       Date:  2006-08       Impact factor: 1.973

Review 5.  Temporal integration of visual signals in lens compensation (a review).

Authors:  Xiaoying Zhu
Journal:  Exp Eye Res       Date:  2013-03-05       Impact factor: 3.467

6.  Temporal properties of compensation for positive and negative spectacle lenses in chicks.

Authors:  Xiaoying Zhu; Josh Wallman
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-12       Impact factor: 4.799

7.  Accommodation and induced myopia in marmosets.

Authors:  David Troilo; Nicole Quinn; Kayla Baker
Journal:  Vision Res       Date:  2007-03-13       Impact factor: 1.886

8.  The effects of longitudinal chromatic aberration and a shift in the peak of the middle-wavelength sensitive cone fundamental on cone contrast.

Authors:  F J Rucker; D Osorio
Journal:  Vision Res       Date:  2008-09       Impact factor: 1.886

9.  The Spatial Frequency Content of Urban and Indoor Environments as a Potential Risk Factor for Myopia Development.

Authors:  Daniel Ian Flitcroft; Elise N Harb; Christine Frances Wildsoet
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-09-01       Impact factor: 4.799

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.